$620 Million is the total value of First Light Asset Management, LLC's 59 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 21.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NEO | Sell | NEOGENOMICS INC | $56,809,000 | -16.1% | 3,700,927 | -28.3% | 9.17% | -13.0% |
| OMCL | Sell | OMNICELL INC | $47,678,000 | +36.5% | 663,109 | -0.5% | 7.69% | +41.4% |
| SHPG | Sell | SHIRE PLC | $41,446,000 | +6.9% | 228,645 | -0.5% | 6.69% | +10.8% |
| ARRY | Sell | ARRAY BIOPHARMA INC | $36,193,000 | -9.8% | 2,381,146 | -0.4% | 5.84% | -6.5% |
| ATRC | Sell | ATRICURE INC | $33,951,000 | -9.1% | 969,193 | -29.8% | 5.48% | -5.8% |
| HBIO | Buy | HARVARD BIOSCIENCE INC | $32,918,000 | +3.4% | 6,270,115 | +5.4% | 5.31% | +7.1% |
| HRTX | Sell | HERON THERAPEUTICS INC | $26,364,000 | -18.9% | 833,001 | -0.4% | 4.25% | -15.9% |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $25,871,000 | +61.8% | 1,594,009 | +28.5% | 4.17% | +67.7% |
| IONS | Sell | IONIS PHARMACEUTICALS INC | $25,385,000 | +23.2% | 492,140 | -0.4% | 4.10% | +27.7% |
| IMMU | Sell | IMMUNOMEDICS INC | $23,988,000 | -12.4% | 1,151,622 | -0.5% | 3.87% | -9.3% |
| NKTR | Sell | NEKTAR THERAPEUTICS | $22,711,000 | +24.3% | 372,551 | -0.5% | 3.66% | +28.8% |
| MODN | Sell | MODEL N INC | $21,153,000 | -15.1% | 1,334,599 | -0.4% | 3.41% | -12.0% |
| LGND | Sell | LIGAND PHARMACEUTICALS INC | $20,043,000 | -21.0% | 73,020 | -40.4% | 3.23% | -18.1% |
| CSII | Sell | CARDIOVASCULAR SYSTEMS INC | $18,962,000 | +20.3% | 484,454 | -0.6% | 3.06% | +24.7% |
| XNCR | Sell | XENCOR INC | $18,224,000 | -12.4% | 467,653 | -16.8% | 2.94% | -9.2% |
| HALO | Sell | HALOZYME THERAPEUTICS INC | $16,090,000 | +7.2% | 885,523 | -0.5% | 2.60% | +11.1% |
| XENT | Buy | INTERSECT ENT INC | $14,867,000 | +74.2% | 517,121 | +126.9% | 2.40% | +80.5% |
| CDXS | Sell | CODEXIS INC | $14,364,000 | +18.6% | 837,548 | -0.5% | 2.32% | +22.9% |
| VCYT | Buy | VERACYTE INC | $11,342,000 | +37.7% | 1,187,694 | +34.7% | 1.83% | +42.6% |
| TNDM | Sell | TANDEM DIABETES CARE INC | $11,305,000 | -73.0% | 263,883 | -86.1% | 1.82% | -72.1% |
| NVTRQ | Sell | NUVECTRA CORP | $8,416,000 | +7.0% | 382,908 | -0.1% | 1.36% | +10.9% |
| KTWO | Sell | K2M GROUP HOLDINGS INC | $7,931,000 | +20.7% | 289,756 | -0.8% | 1.28% | +25.1% |
| DVAX | Sell | DYNAVAX TECHNOLOGIES CORP | $6,774,000 | -19.1% | 546,265 | -0.5% | 1.09% | -16.1% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $6,041,000 | +2.2% | 62,298 | -0.7% | 0.98% | +6.0% |
| GMED | Sell | GLOBUS MEDICAL INC | $5,898,000 | +11.7% | 103,908 | -0.7% | 0.95% | +15.8% |
| LHCG | Sell | LHC GROUP INC | $5,556,000 | +19.4% | 53,947 | -0.8% | 0.90% | +23.8% |
| TECH | Sell | BIO TECHNE CORP | $5,147,000 | -15.3% | 25,216 | -38.6% | 0.83% | -12.3% |
| BLUE | Sell | BLUEBIRD BIO INC | $4,850,000 | -7.4% | 33,217 | -0.4% | 0.78% | -3.9% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $4,777,000 | +12.5% | 24,787 | -0.7% | 0.77% | +16.6% |
| TLGT | Sell | TELIGENT INC | $4,523,000 | +13.6% | 1,145,096 | -0.5% | 0.73% | +17.7% |
| KIDS | Sell | ORTHOPEDIATRICS CORP | $4,516,000 | +36.6% | 123,241 | -0.7% | 0.73% | +41.6% |
| SGMO | Buy | SANGAMO THERAPEUTICS INC | $4,507,000 | +104.3% | 265,877 | +71.1% | 0.73% | +112.0% |
| NXTM | Sell | NXSTAGE MEDICAL INC | $4,217,000 | -0.8% | 151,207 | -0.8% | 0.68% | +2.7% |
| QDEL | Sell | QUIDEL CORP | $3,576,000 | -33.4% | 54,878 | -32.0% | 0.58% | -31.0% |
| HSTM | Sell | HEALTHSTREAM INC | $2,821,000 | +12.7% | 90,986 | -0.7% | 0.46% | +16.7% |
| IBB | ISHARES NASDAQ BIOTECHNOLOGY ETFetf | $2,596,000 | +11.0% | 21,291 | 0.0% | 0.42% | +15.1% | |
| PSCH | New | INVESCO SMALLCAP HEALTH CARE ETFetf | $2,426,000 | – | 17,285 | +100.0% | 0.39% | – |
| CLLS | New | CELLECTIS SA | $2,154,000 | – | 76,325 | +100.0% | 0.35% | – |
| LMAT | Sell | LEMAITRE VASCULAR INC | $1,922,000 | +14.8% | 49,617 | -0.8% | 0.31% | +18.8% |
| XLV | HEALTH CARE SELECT SECTOR SPDR ETFetf | $1,736,000 | +14.1% | 18,241 | 0.0% | 0.28% | +18.1% | |
| IHI | ISHARES US MEDICAL DEVICES ETFetf | $1,724,000 | +13.3% | 7,580 | 0.0% | 0.28% | +17.3% | |
| ALKS | Sell | ALKERMES PLC | $1,359,000 | +2.3% | 32,032 | -0.7% | 0.22% | +5.8% |
| SLP | New | SIMULATIONS PLUS INC | $1,162,000 | – | 57,548 | +100.0% | 0.19% | – |
| RMED | New | RA Medical Systems, Inc. | $1,092,000 | – | 60,000 | +100.0% | 0.18% | – |
| ENZ | Sell | ENZO BIOCHEM INC | $775,000 | -21.2% | 188,159 | -0.8% | 0.12% | -18.3% |
| ABBV | ABBVIE | $393,000 | +2.1% | 4,159 | 0.0% | 0.06% | +5.0% | |
| PFE | PFIZER INC | $377,000 | +21.6% | 8,558 | 0.0% | 0.06% | +27.1% | |
| DYNT | Buy | DYNATRONICS CORP | $316,000 | +1.0% | 110,811 | +1.8% | 0.05% | +4.1% |
| NVS | NOVARTIS A G | $308,000 | +14.1% | 3,572 | 0.0% | 0.05% | +19.0% | |
| JNJ | JOHNSON AND JOHNSON | $302,000 | +14.0% | 2,183 | 0.0% | 0.05% | +19.5% | |
| MRK | MERCK & CO INC | $305,000 | +16.9% | 4,294 | 0.0% | 0.05% | +19.5% | |
| SNY | SANOFI-SYNTHELABO | $300,000 | +11.5% | 6,720 | 0.0% | 0.05% | +14.3% | |
| AMGN | AMGEN INC | $229,000 | +12.3% | 1,105 | 0.0% | 0.04% | +15.6% | |
| PKI | New | PERKINELMER INC | $221,000 | – | 2,270 | +100.0% | 0.04% | – |
| ANTM | New | ANTHEM INC COM | $220,000 | – | 803 | +100.0% | 0.04% | – |
| TFX | TELEFLEX INCORPORATED | $208,000 | -1.0% | 783 | 0.0% | 0.03% | +3.0% | |
| HCA | New | HCA HOLDINGS INC | $210,000 | – | 1,513 | +100.0% | 0.03% | – |
| HRC | New | HILL-ROM HOLDINGS INC | $202,000 | – | 2,144 | +100.0% | 0.03% | – |
| STRM | Sell | STREAMLINE HEALTH SOLUTIONS | $47,000 | -98.1% | 39,701 | -97.7% | 0.01% | -97.9% |
| CELG | Exit | CELGENE CORP | $0 | – | -14,742 | -100.0% | -0.18% | – |
| IRIX | Exit | IRIDEX CORP | $0 | – | -198,581 | -100.0% | -0.22% | – |
| PSCH | Exit | POWERSHARES S&P SMALLCAP HEALTH CARE ETFetf | $0 | – | -17,285 | -100.0% | -0.35% | – |
| NVRO | Exit | NEVRO CORP | $0 | – | -116,224 | -100.0% | -1.44% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ATRICURE INC | 40 | Q3 2023 | 9.7% |
| NEOGENOMICS INC | 40 | Q3 2023 | 10.6% |
| SANOFI-SYNTHELABO | 40 | Q3 2023 | 1.9% |
| JOHNSON & JOHNSON | 40 | Q3 2023 | 0.3% |
| PFIZER INC | 39 | Q2 2023 | 0.9% |
| BIOMARIN PHARMACEUTICAL INC | 36 | Q3 2023 | 1.6% |
| OMNICELL INC | 33 | Q3 2023 | 7.7% |
| QUIDEL CORP | 33 | Q4 2021 | 3.7% |
| NOVARTIS AG-SPONSORED ADR | 33 | Q3 2023 | 0.4% |
| MODEL N INC | 30 | Q3 2023 | 9.0% |
View First Light Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| REATA PHARMACEUTICALS INC | May 15, 2023 | 1,290,193 | 3.9% |
| Axogen, Inc. | February 03, 2023 | 1,942,270 | 4.6% |
| MODEL N, INC. | February 03, 2023 | 1,845,134 | 4.9% |
| MEI Pharma, Inc.Sold out | May 31, 2022 | 0 | 0.0% |
| PROTHENA CORP PUBLIC LTD CO | March 01, 2022 | 1,805,038 | 3.9% |
| Intersect ENT, Inc. | February 14, 2022 | 1,375,210 | 4.1% |
| SeaSpine Holdings Corp | February 14, 2022 | 6,847,707 | 18.8% |
| Oxford Immunotec Global PLCSold out | February 10, 2021 | 0 | 0.0% |
| ENDOLOGIX INC /DE/ | February 14, 2020 | 816,236 | 4.6% |
| Nuvectra CorpSold out | February 14, 2020 | 0 | 0.0% |
View First Light Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-09 |
| 4 | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
View First Light Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.